In patients with prostate cancer, accurate primary staging is important for developing a treatment strategy. A study published in the December issue of the Journal of Nuclear Medicine found whole-body PET/MRI may offer a “one-stop-shop” to do so.

The Washington University School of Medicine in St. Louis (WUSTL) was awarded a five-year, $6.3 million grant to establish a new research center to develop and test novel PET tracers.

Artificial intelligence (AI) can generate high-quality amyloid PET images from simultaneously acquired MR images and ultra-low-dose PET data, according to a Dec. 11 study published in Radiology.

PET imaging may hold promise for personalizing treatment in patients with tuberculosis meningitis (TBM), a rare disease that leaves some survivors with permanent brain damage, reported researchers from Johns Hopkins University School of Medicine in Baltimore.

Authors of a recent study reported improved survival in patients with aggressive non-Hodgkin lymphoma (HL) whose first-line therapy was guided by PET/CT instead of CT alone.

The use of [18F]Fluciclovine-PET imaging is steadily increasing in patients with suspected prostate cancer, but a new single-center study published in the Journal of the American College of Radiology found some have more difficulty undergoing the exam than others.

The Molybdenum-99 (Mo-99) shortage is expected to subside over the coming few weeks as generators across the globe slowly begin to resume production, according to the Society for Nuclear Medicine and Molecular Imaging (SNMMI).

While the number of female medical students has risen, women specialists remain underrepresented in nuclear medicine in the U.S. and Canada—specifically in academic and leadership positions, according to a recent study published in the American Journal of Roentgenology.